ethers, cyclic

Preferred Label : ethers, cyclic;

MeSH definition : Compounds of the general formula R-O-R arranged in a ring or crown formation.;

MeSH synonym : cyclic ethers; Cyclic Ether; Ether, Cyclic;

Wikipedia automatic translation : Ether;

Wikipedia link : https://en.wikipedia.org/wiki/Ether;

Is substance : O;

Details

Origin ID

D004988;

UMLS CUI

C0014997;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Record concept(s)
- ethers, cyclic [MeSH concept]
Related MeSH Supplementary Concept(s)
- (2,9,25,32-tetraoxo-4,7,27,30-tetrakis(carboxymethyl)-1,4,7,10,24,27,30,33-octaaza-17,40-dioxa(10.1.10.1)paracyclophane)copper(II) [MeSH Supplementary Concept]
- 1,11-bis(8-quinolinyloxy)-3,6,9-trioxaundecane [MeSH Supplementary Concept]
- 1-desulfoyessotoxin [MeSH Supplementary Concept]
- 1-norokadaone [MeSH Supplementary Concept]
- 12-epoxyobtusallene IV [MeSH Supplementary Concept]
- 17,18-dihydro-5H,9H-dibenzo(e,n)(1,4,10,7,13)trioxadiazacyclopentadecine-6,10(7H,11H)-dione [MeSH Supplementary Concept]
- 2-chloro-3-(bromomethyl)oxirane [MeSH Supplementary Concept]
- 2-methyleneoxetane [MeSH Supplementary Concept]
- 21-(4'-methoxyphenylazo)-1,4,7,14,23-pentaoxa(7.2.2)orthometaorthobenzenophane [MeSH Supplementary Concept]
- 27-methyl 7-O-(4-azidobenzoyl)okadaate [MeSH Supplementary Concept]
- 3,3-bis(hydroxymethyl)oxetane [MeSH Supplementary Concept]
- 3,3-bis(nitroxymethyl)oxetane [MeSH Supplementary Concept]
- 3-oxetanone [MeSH Supplementary Concept]
- 3-pinnatifidenyne [MeSH Supplementary Concept]
- 39-oxobistramide K [MeSH Supplementary Concept]
- 42,43,44,45,46,47,55-heptanor-41-oxohomoyessotoxin [MeSH Supplementary Concept]
- 45-hydroxyyessotoxin [MeSH Supplementary Concept]
- 5-phenylpentyl N-((2S,3R)-2-methyl-4-oxo-oxetan-3-yl)carbamate [MeSH Supplementary Concept]
- 6,7,9,10-tetrahydro-16H,20H-dibenzo(h,q)1,4,7,13,10,16-tetraoxadiazacyclooctadecine-27,21(18H,22H)-dione [MeSH Supplementary Concept]
- 6,7-(4-methyl)coumaro-(2.2.2)cryptand [MeSH Supplementary Concept]
- 9,10,20,21-tetrahydro-5H,12H-dibenzo(e,q)(1,4,10.13,7,16)tetraoxadiazacyclooctadecine-6,13(7H,14H)-dione [MeSH Supplementary Concept]
- CP 72588 [MeSH Supplementary Concept]
- CPPy compound [MeSH Supplementary Concept]
- FCryp-2 [MeSH Supplementary Concept]
- LL-Z 1220 [MeSH Supplementary Concept]
- MMS350 [MeSH Supplementary Concept]
- MPK-09 [MeSH Supplementary Concept]
- N-(2-oxo-3-oxetanyl)biphenyl-4-carboxamide [MeSH Supplementary Concept]
- N-(aminoacetyl)-1-aza-4,7,10-13-tetraoxacyclopentadecane [MeSH Supplementary Concept]
- OH-dibenzo-14-crown-4 [MeSH Supplementary Concept]
- W 341C [MeSH Supplementary Concept]
- X-206, polyether antibiotic [MeSH Supplementary Concept]
- acanthifolicin methyl ester [MeSH Supplementary Concept]
- aminohydroxy epoxybenzoxocin [MeSH Supplementary Concept]
- ascospiroketal A [MeSH Supplementary Concept]
- ascospiroketal B [MeSH Supplementary Concept]
- attenol A [MeSH Supplementary Concept]
- aurilol [MeSH Supplementary Concept]
- bis(dihydrofuryl)cyclophane [MeSH Supplementary Concept]
- bis(metacyclophane)bolaamphiphile [MeSH Supplementary Concept]
- bistramide C [MeSH Supplementary Concept]
- bistramide D [MeSH Supplementary Concept]
- bistramide K [MeSH Supplementary Concept]
- bistratene B [MeSH Supplementary Concept]
- bradyoxetin [MeSH Supplementary Concept]
- brasilenyne [MeSH Supplementary Concept]
- brevisin [MeSH Supplementary Concept]
- brevisulcenal-F [MeSH Supplementary Concept]
- briarellin E [MeSH Supplementary Concept]
- briarellin F [MeSH Supplementary Concept]
- calix(6)aza-cryptand [MeSH Supplementary Concept]
- carboxyhomoyessotoxin [MeSH Supplementary Concept]
- cavicularin [MeSH Supplementary Concept]
- cavitand [MeSH Supplementary Concept]
- cavitand 4 [MeSH Supplementary Concept]
- cavitand 5 [MeSH Supplementary Concept]
- cavitand 6 [MeSH Supplementary Concept]
- cavitand 7 [MeSH Supplementary Concept]
- cavitein LG2 [MeSH Supplementary Concept]
- cavitein LG3 [MeSH Supplementary Concept]
- chrysophaentin A [MeSH Supplementary Concept]
- conduritol E [MeSH Supplementary Concept]
- cryptand [MeSH Supplementary Concept]
- cyclophane 1 [MeSH Supplementary Concept]
- cyclophane 2 [MeSH Supplementary Concept]
- cyclophane 3 [MeSH Supplementary Concept]
- cyclopropanol [MeSH Supplementary Concept]
- enshuol [MeSH Supplementary Concept]
- epostatin [MeSH Supplementary Concept]
- ethylene brassylate [MeSH Supplementary Concept]
- gracilioether E [MeSH Supplementary Concept]
- gymnocin A [MeSH Supplementary Concept]
- gymnocin-B [MeSH Supplementary Concept]
- halichondrin A [MeSH Supplementary Concept]
- halichondrin B [MeSH Supplementary Concept]
- halichondrin C [MeSH Supplementary Concept]
- homohalichondrin B [MeSH Supplementary Concept]
- homooxacalix(3)arene triether [MeSH Supplementary Concept]
- kramecyne [MeSH Supplementary Concept]
- laureatin [MeSH Supplementary Concept]
- lauthisan [MeSH Supplementary Concept]
- macrolactin 1 [MeSH Supplementary Concept]
- macrolactin 2 [MeSH Supplementary Concept]
- macrolactin 3 [MeSH Supplementary Concept]
- malyngolide dimer [MeSH Supplementary Concept]
- marchantin A [MeSH Supplementary Concept]
- marchantin A trimethyl ether [MeSH Supplementary Concept]
- marchantin H [MeSH Supplementary Concept]
- marchantinquinone [MeSH Supplementary Concept]
- methyl okadaate [MeSH Supplementary Concept]
- nivariol [MeSH Supplementary Concept]
- obtusallene [MeSH Supplementary Concept]
- obtusenyne [MeSH Supplementary Concept]
- ovalifoliolatin A [MeSH Supplementary Concept]
- ovalifoliolatin B [MeSH Supplementary Concept]
- oviedomycin [MeSH Supplementary Concept]
- oxetan-3-tert-butylsulfinimine [MeSH Supplementary Concept]
- oxetane [MeSH Supplementary Concept]
- oxetin [MeSH Supplementary Concept]
- pakyonol [MeSH Supplementary Concept]
- pharacine [MeSH Supplementary Concept]
- pinnatifidenyne [MeSH Supplementary Concept]
- pondaplin [MeSH Supplementary Concept]
- potassium-binding benzofuran isophthalate [MeSH Supplementary Concept]
- potassium-binding benzofuran-isophthalate acetoxymethyl ester [MeSH Supplementary Concept]
- pyridinophane cryptand [MeSH Supplementary Concept]
- rhodium tetrathiacyclohexadecanediol dichloride [MeSH Supplementary Concept]
- riccardin A [MeSH Supplementary Concept]
- riccardin C [MeSH Supplementary Concept]
- riccardin F [MeSH Supplementary Concept]
- rubrobramide [MeSH Supplementary Concept]
- sodium-binding benzofuran isophthalate [MeSH Supplementary Concept]
- sodium-binding benzofuran phthalate [MeSH Supplementary Concept]
- spiroether [MeSH Supplementary Concept]
- vigulariol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients